Personalized Kidney Screening Could Reduce Type 1 Diabetes Costs

November 2, 2022 by Dan McCue
Personalized Kidney Screening Could Reduce Type 1 Diabetes Costs
(National Institute of Diabetes and Digestive and Kidney Diseases photo)

WASHINGTON — Taking a personalized approach to kidney disease screening for people with type 1 diabetes may reduce the time chronic kidney disease goes undetected and reduce the cost of treatment, according to a new study.

The new analysis, which was performed by the Epidemiology of Diabetes Interventions and Complications study group, was published in the journal Diabetes Care.

According to the study, current chronic kidney disease screening recommendations typically include annual urinary albumin excretion rate testing for anyone who has had T1D for at least five years. 

Albumin is a protein found in the blood and having too much albumin in the urine is a sign of kidney disease. 


The new findings, however, suggest that albumin excretion rate screening could be personalized to optimize testing frequency and early detection of chronic kidney disease.  

Specifically, the researchers suggest, people with T1D who are at low risk of developing chronic kidney disease could be tested for albumin excretion rate less frequently to reduce burden and cost, and those at high risk for chronic kidney disease could be tested more frequently to facilitate earlier detection.

People with T1D have an estimated 50% risk of developing chronic kidney disease over their lifetime. Chronic kidney disease can progress to kidney failure, requiring dialysis or a kidney transplant. 

Using more than 30 years of participant data of albumin excretion rate testing and HbA1c (an integrated measure of blood glucose) from 1,334 participants in the NIDDK-funded Diabetes Control and Complications Trial and the observational follow-up Epidemiology of Diabetes Interventions and Complications study, the study group identified three levels of chronic kidney disease risk that were associated with a later diagnosis. 


They then developed a model to estimate the optimal screening intervals for people with T1D to detect chronic kidney disease at its earliest stages.

According to the model’s findings, people with albumin excretion rate of 21-30 mg per 24 hours and a HbA1c of at least 9% are at high risk for developing chronic kidney disease and could be screened for urine albumin every six months. 

This screening frequency could reduce time with undetected kidney disease so that appropriate interventions can be instituted as early as possible.

Those with albumin excretion rate ≤ 10 mg per 24 hours and a HbA1c ≤ 8% are at lower risk for developing chronic kidney disease and could be screened every two years. This change reduces patient burden and potentially saves millions of dollars compared to annual screening.

All others with T1D ≥ 5 years could continue to be screened annually.

The DCCT, which took place from 1983 to 1993, found that, for people with T1D, keeping blood glucose levels close to normal greatly reduced the chances of developing eye, kidney and nerve disease. Its follow-up study, EDIC, began in 1994 to explore how diabetes affects the body over time and the long-term benefits of early and intensive blood glucose control in the development of later diabetes complications.


The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases, which is part of the National Institutes of Health.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue.

A+
a-

In The News

Health

Voting

Health

Schools Struggle to Staff Up for Youth Mental Health Crisis

Mira Ugwuadu felt anxious and depressed when she returned to her high school in Cobb County, Georgia, last fall after... Read More

Mira Ugwuadu felt anxious and depressed when she returned to her high school in Cobb County, Georgia, last fall after months of remote learning, so she sought help. But her school counselor kept rescheduling their meetings because she had so many students to see. “I felt... Read More

November 17, 2022
by Dan McCue
FDA Conditionally Approves First Drug to Manage Acute Pancreatitis in Dogs

WASHINGTON — The Food and Drug Administration has conditionally approved Panoquell-CA1 for the management of clinical signs associated with acute... Read More

WASHINGTON — The Food and Drug Administration has conditionally approved Panoquell-CA1 for the management of clinical signs associated with acute onset of pancreatitis in dogs.  Panoquell-CA1 is an injectable drug intended for use while the dog is hospitalized for treatment of the disease.   Pancreatitis is a... Read More

November 15, 2022
by TWN Staff
Case Western Reserve University Awarded $7.3M for Eye Research

CLEVELAND — Case Western Reserve University School of Medicine has been awarded a five-year, $7.3 million grant from the National... Read More

CLEVELAND — Case Western Reserve University School of Medicine has been awarded a five-year, $7.3 million grant from the National Institutes of Health to identify new technology, methods and models to study the impact of inflammation and pain on the surface of the eye. “The cornea... Read More

November 15, 2022
by TWN Staff
Improved Eye Care Could Have Prevented Dementia Cases, Study Says

WASHINGTON — A study recently published in the journal JAMA Neurology suggests that as many as 100,000 U.S. dementia cases... Read More

WASHINGTON — A study recently published in the journal JAMA Neurology suggests that as many as 100,000 U.S. dementia cases could possibly have been prevented with improved eye care. The National Institute on Aging-funded research used data from a University of Michigan Health Retirement Study that... Read More

November 15, 2022
by Dan McCue
Google Pilot Testing Health Care Records Tool

Google is pilot testing the integration of its Google Care Studio search tool into the health records of two health... Read More

Google is pilot testing the integration of its Google Care Studio search tool into the health records of two health systems, one in Alabama and the other in Wisconsin. According to a recent JAMA Network Open study, poor access to the information clinicians need is leading... Read More

November 15, 2022
by Dan McCue
Report Finds Cancer Deaths Continue Downward Trend

WASHINGTON — The death rate from most cancers continued to decline over a four-year period extending from 2015 to 2019,... Read More

WASHINGTON — The death rate from most cancers continued to decline over a four-year period extending from 2015 to 2019, according to the latest Annual Report to the Nation on the State of Cancer from the National Institutes of Health. During roughly the same period, the... Read More

News From The Well
scroll top